Loading
MediPharm Labs Corp. Stock: price and insider trades · Canada
MediPharm Labs Corp.: what insiders have been doing
This page follows insider dealings at MediPharm Labs Corp. as filed with SEDI, a company from the Health Care sector. In the past year (23 October 2025 to 23 October 2026), 30 filings came from 9 insiders.
All open-market trades in the period are sales: 1 sale worth €8,219, by 1 insider, with no purchase on record. The largest single trade was a sale of €8,219 by Taves, Christopher David, published on 12 June 2026.
Typically, a trade is published a median of 6 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Across the 2,471 companies tracked on its exchange, the median is 12 filings; at 30 filings, this issuer sits above that mark. Over the whole record (from 2021), the tally stands at 9 purchases and 16 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
116
Thresholds
n/a
Buy Volume
€7M
9 ops. · all time
Sell Volume
€1M
16 ops. · all time
Who traded when
BuySaleChristopher David Taves1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,708 of 26,250 companies
16.7
score / 100
Value9
Quality24
FCF yld-20%
Earn yld-30%
EV/EBITDA·
ROE-13%
Gross mgn31%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.07
Analyst consensus
Income statement
RevenueCA$45.1M
Gross profitCA$14M31% margin
EBITDA-CA$6.5M-15% margin
Net income-CA$8.3M-12.0% margin
Valuation
P/Book0.8x
Beta0.85
Balance sheet & cash
Market capCA$27.8M
Total debtCA$201k
Free Cash Flow-CA$5.6M
Debt / Equity1%
Profitability & ownership
ROE-13.2%
ROA-5.2%
% insiders11.6%
% institutions0.0%
Last declaration on 14 September 2026
Declarations116 total
401,069 sharesRestricted Stock UnitsTSXSEDI:4777242
176,785 sharesCommon SharesTSXSEDI:4755231
321,429 sharesRestricted Stock UnitsTSXSEDI:4755226
302,142 sharesCommon SharesTSXSEDI:4735919
604,286 sharesRestricted Stock UnitsTSXSEDI:4735915
98,214 sharesCommon SharesTSXSEDI:4735912
178,571 sharesRestricted Stock UnitsTSXSEDI:4735911
300,000 sharesOptionsTSXSEDI:4735910
88,393 sharesCommon SharesTSXSEDI:4735908
160,715 sharesRestricted Stock UnitsTSXSEDI:4735906
98,214 sharesCommon SharesTSXSEDI:4735904
178,572 sharesRestricted Stock UnitsTSXSEDI:4735903
176,786 shares@ CA$0.075100.0% of flowCommon SharesTSXSEDI:4734542
392,857 sharesCommon SharesTSXSEDI:4734541
392,857 sharesRestricted Stock UnitsTSXSEDI:4734540
183,214 sharesCommon SharesTSXSEDI:4734089
366,429 sharesRestricted Stock UnitsTSXSEDI:4734088
50,000 sharesOptionsTSXSEDI:4733086
600,000 sharesOptionsTSXSEDI:4733084
2,051,020 sharesOptionsTSXSEDI:4733031
1,285,714 sharesRestricted Stock UnitsTSXSEDI:4732841
392,858 sharesCommon SharesTSXSEDI:4622020
74,683 sharesCommon SharesTSXSEDI:4622018
313,136 sharesCommon SharesTSXSEDI:4622008
82,982 sharesCommon SharesTSXSEDI:4621997
25 of 116 declarations
About MediPharm Labs Corp.
MediPharm Labs Corp. is a company focused on the production of cannabinoids for medical purposes. It is listed on the Toronto Stock Exchange under the symbol XTSE.
